CASE REPORT
Published on 06 Aug 2026
Emergence of EGFR C797S as a resistance mechanism to CLN081 in EGFR exon 20–mutant NSCLC: case report
doi 10.3389/fonc.2026.1812440
- 1,164 views
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Targeting Epigenetic Regulators in Cancer Therapy: From Drug Resistance Mechanisms to Precision Interventions
Targeting Epigenetic Regulators in Cancer Therapy: From Drug Resistance Mechanisms to Precision Interventions
1,445
Total downloads
13k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 17 Jul 2026
Research progress of small molecule protein kinase inhibitors (SMKIs) in the treatment of colorectal cancer: mechanism, application, and future prospects
doi 10.3389/fphar.2026.1782130
- 818 views
ORIGINAL RESEARCH
Published on 19 May 2026
BRD4 PROTAC degrader enhances fulvestrant sensitivity in ER+ breast cancer via super-enhancer associated GREB1
doi 10.3389/fonc.2026.1828900
- 1,436 views
REVIEW
Published on 01 May 2026
PARylation-centric crosstalk: orchestrating immune evasion and multidrug resistance in ovarian cancer
doi 10.3389/fimmu.2026.1772562
- 2,355 views
ORIGINAL RESEARCH
Published on 31 Mar 2026
Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model
doi 10.3389/fonc.2026.1721685
- 1,590 views
REVIEW
Published on 27 Feb 2026
Epigenetic and mitoepigenetic regulation in cancer and therapeutic perspectives
doi 10.3389/fphar.2026.1760013
- 1,888 views
- 1 citation
ORIGINAL RESEARCH
Accepted on 24 Jul 2026
MiR-150-5p suppresses high-grade transformation of lacrimal adenoid cystic carcinoma by downregulating COL1A1
- 202 views
ORIGINAL RESEARCH
Accepted on 29 Jul 2026
Indole-3-Acetic Acid-Derived Carbon Dots Inhibit the Malignant Progression of Colorectal Cancer via Negative Regulation of the MAPK/ERK Pathway
- 200 views
ORIGINAL RESEARCH
Accepted on 10 Aug 2026
Phellinus igniarius-Derived Carbon Dots Suppress Liver Cancer Through the ROS/MAPK Signaling Axis
- 149 views
ORIGINAL RESEARCH
Accepted on 17 Aug 2026
Extrachromosomal circular DNA drives focal amplification of AGAP2-AS1 to promote cutaneous tumorigenesis
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Other participating journals
Frontiers in Pharmacology
- 5.4 impact factor
- 9.5 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: